Mirum Pharmaceuticals (MIRM) Change in Acquisitions & Divestments (2019 - 2026)

Mirum Pharmaceuticals' Change in Acquisitions & Divestments history runs 8 years deep, the most recent figure standing at $33.9 million for Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments rose 94.41% year-over-year to $33.9 million in Q1 2026; TTM through Mar 2026 was $90.9 million, a 143.48% increase from a year earlier, with the FY2025 full-year figure at $74.4 million, up 274.11% from the prior year.
• Change in Acquisitions & Divestments rose to $33.9 million in Q1 2026 per MIRM's latest filing, from $13.1 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $64.5 million in Q1 2023 and bottomed at $3.0 million in Q4 2023.
• The 5-year median for Change in Acquisitions & Divestments is $27.0 million (2022), against an average of $28.1 million.
• Across the five-year window, Change in Acquisitions & Divestments tumbled 88.89% in 2023 and surged 304.8% in 2024, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $27.0 million in 2022, then tumbled by 88.89% to $3.0 million in 2023, then jumped by 304.8% to $12.1 million in 2024, then advanced by 7.94% to $13.1 million in 2025, then jumped by 158.56% to $33.9 million in 2026.
• Per Business Quant, the three latest MIRM Change in Acquisitions & Divestments figures stand at $33.9 million (Q1 2026), $13.1 million (Q4 2025), and $18.8 million (Q3 2025).